子宫肌瘤
月经出血
激素
医学
月经周期
激素拮抗剂
敌手
妇科
内科学
内分泌系统
受体
作者
William D. Schlaff,Ronald Ackerman,Ayman Al‐Hendy,David F. Archer,Kurt T. Barnhart,D.A. Bradley,Bruce R. Carr,Eve C. Feinberg,Sandra Hurtado,Jin Hee Kim,Ran Liu,R. Garn Mabey,Charlotte D. Owens,Alfred N. Poindexter,Elizabeth E. Puscheck,Henry Rodriguez-Ginorio,James A. Simon,Ahmed M. Soliman,Elizabeth A. Stewart,Nelson B. Watts,Ozgul Muneyyirci‐Delale
标识
DOI:10.1056/nejmoa1904351
摘要
Uterine fibroids are hormone-responsive neoplasms that are associated with heavy menstrual bleeding. Elagolix, an oral gonadotropin-releasing hormone antagonist resulting in rapid, reversible suppression of ovarian sex hormones, may reduce fibroid-associated bleeding.
科研通智能强力驱动
Strongly Powered by AbleSci AI